7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells.
Yasaman AbolhassaniSara MirzaeiMasoud NejabatSeyedehsaba TalebianHamid GholamhosseinianMehrdad IranshahiMohammad Reza KeramatiKhadijeh JamialahmadiPublished in: Molecular biology reports (2023)
The findings of the present study indicated, for the first time, that AUR improved radio sensitivity in prostate cancer cells, and thus, has the potential to be used in future clinical trials.